Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study

BACKGROUND: Sacubitril/valsartan is an effective treatment for heart failure with reduced ejection fraction (HFrEF) based on clinical trial data. However, little is known about its use or impact in real-world practice. The aim of this study was to describe our routine clinical experience of switchin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Heart
Main Authors: Ganesananthan, Sashiananthan, Shah, Nisar, Shah, Parin, Elsayed, Hossam, Phillips, Julie, Parkes, Ann, Morgan, Angharad, Yousef, Zaheer
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Heart Failure and Cardiomyopathies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537464/
https://ncbi.nlm.nih.gov/pubmed/33020255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2020-001305
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados